Bristol Myers Squibb Canada Co., a subsidiary of the renowned global biopharmaceutical company Bristol Myers Squibb, is headquartered in Canada and operates extensively across the country. Founded in 1887, the company has established itself as a leader in the pharmaceutical industry, focusing on innovative medicines in areas such as oncology, immunology, and cardiovascular disease. Bristol Myers Squibb is known for its commitment to research and development, with core products that include groundbreaking therapies like Opdivo and Eliquis, which have transformed treatment paradigms. The company’s dedication to advancing science and improving patient outcomes has positioned it as a key player in the Canadian healthcare landscape. With a strong emphasis on collaboration and innovation, Bristol Myers Squibb continues to achieve notable milestones in the fight against serious diseases.
We don't have data for Bristol Myers Squibb Canada Co., but we can show you information about their parent organization instead.
View parent company